Shire Files NDA For Longer-Acting Adult ADHD Treatment
This article was originally published in The Pink Sheet Daily
Executive Summary
Shire's NDA submission for SPD465 could allow the firm to be the first to offer a 16-hour attention deficit/hyperactivity disorder treatment